The legislation proposes to increase funding for the National Institutes of Health by creating a new statutory scheme that would impose a fee on biopharmaceutical companies working on critical treatments and cures for patients. "While we greatly support the idea of increased funding for NIH, we have serious concerns about the impact that this legislation would have on the research and development of new treatments and cures.
http://ift.tt/1HrniHe
http://ift.tt/1HrniHe
No comments:
Post a Comment